Chaurasia A,
Singh N, D Sahu D, Mishra A. Comparative Evaluation of role of Lysyl oxidase
gene (LOXG473A) expression in pathogenesis and malignant transformation of Oral
Submucous Fibrosis. J Clin Exp Dent. 2019;11(10):e858-64.
doi:10.4317/jced.55980
https://doi.org/10.4317/jced.55980
____________________________________________________________________________________________________________________________________________________________________
References
1.
Rajalalitha P, Vali S. Molecular pathogenesis of oral submucous fibrosis- a
collagen metabolic disorder. J Oral Pathol Med. 2005;34:321-8. |
|
|
|
2.
Shieh TM, Tu HF, Chang KW, Liu CJ. Association between lysyl oxidase
polymorphisms and oral submucous fibrosis in older male areca nut chewers. J
oral Pathol Med. 2009;38:109-13. |
|
|
|
3.
Cox SC, Walker DM. Oral submucous fibrosis-A review. Aust Dent J. 1996;41:294-9. |
|
|
|
4.
Trivedy CR, Warnakualsuriya KA, Peters TJ, Senkus R, Hazarey VK, Jhonson KW.
Raised tissue copper levels in Oral submucous fibrosis. J oral pathol Med.
2000;29:241-8. |
|
|
|
5.
Sheih TM, Lin SC, Lie CJ, Chang SS, KU TH, Chang KW. Association of
expression abberances and genetic polymorphisms of lysyl oxidase with areca
associated oral tumorogenesis. Clin Cancer Res. 2007;13:4378-85. |
|
|
|
6.
Schache M, Baired PN . Assesment of the association of matrix
metalloproteinases with myopia, refractive error and ocular biometric
measures in an Australian cohort. PLos one. 2012;7:471-81. |
|
|
|
7.
Tilakaratne WM, Klinikowski MF, Saku T, Peters TJ, Warnakulasuriya S. Oral
submucous fibrosis: review on aetiology and pathogenesis. Oral Oncol. 2006;42:561-8. |
|
|
|
8.
Cox SC, Walker DM. Oral submucous fibrosis. A review. Aust Dent J. 1996;41:294-9. |
|
|
|
9.
Yang YH, Lee HY, Tung S, Shieh TY. Epidemiological survey of oral submucous
fibrosis and leukoplakia in aborigines of Taiwan. J Oral Pathol Med. 2001;30:213-9. |
|
|
|
10.
Canniff JP, Harvey W, Harris M. Oral submucous fibrosis: its pathogenesis and
management. Br Dent J. 1986;160:429-34. |
|
|
|
11.
Seedat HA, van Wyk CW. Betel-nut chewing and sub- mucous fibrosis in Durban. S
Afr Med J. 1988;74:568-71. PMid:3194805 |
|
|
|
12.
Maher R, Lee AJ, Warnakulasuriya KA, Lewis JA, Johnson NW. Role of areca nut
in the causation of oral submucous fibrosis: a case-control study in Pakistan.
J Oral Pathol Med. 1994;23:65-9. |
|
|
|
13.
Zain RB, Ikeda N, Razak IA, et al. A national epidemi- ological survey of
oral mucosal lesions in Malaysia. Community Dent Oral Epidemiol. 1997;25:377-83. |
|
|
|
14.
Sinor PN, Gupta PC, Murti PR, et al. A case-control study of oral submucous
fibrosis with special reference to the etiologic role of areca nut. J Oral
Pathol Med. 1990;19:94-8. |
|
|
|
15.
Tang JG, Jian XF, Gao ML, Ling TY, Zhang KH. Epidemiological survey of oral
submucous fibrosis in Xiangtan City, Hunan Province, China. Community Dent Oral
Epidemiol. 1997;25:177-80. |
|
|
|
16.
Gupta PC, Hebert JR, Bhonsle RB, Sinor PN, Mehta H, Mehta FS. Dietary factors
in oral leukoplakia and submucous fibrosis in a population-based case control
study in Gujarat, India. Oral Dis. 1998;4:200-6. |
|
|
|
17.
Seedat HA, van WykCW. Submucous fibrosis (SF) in ex-betel nut chewers: a
report of 14 cases. J Oral Pathol. 1988;17:226-9. PMid:3144586 |
|
|
|
18.
Chang YC, Yang SF, Tai KW, Chou MY, Hsieh YS. Increased tissue inhibitor of
metalloproteinase-1 expres- sion and inhibition of gelatinase A activity in
buccal mucosal fibroblasts by arecoline as possible mechanisms for oral
submucous fibrosis. Oral Oncol. 2002;38:195-200. |
|
|
|
19.
Shieh DH, Chiang LC, Shieh TY. Augmented mRNA expression of tissue inhibitor
of metalloproteinase-1 in buccal mucosal fibroblasts by arecoline and safrole
as a possible pathogenesis for oral submucous fibrosis. Oral Oncol. 2003;9:728-35. PMid:12907213 |
|
|
|
20.
Scutt A, Meghji S, Canniff JP, Harvey W. Stabilisation of collagen by betel
nut polyphenols as a mechanism in oral submucous fibrosis. Experientia.
1987;43:391-3. |
|
|
|
21.
Tsai CH, Chou MY, Chang YC. The up-regulation of cyclooxygenase-2 expression
in human buccal mucosal fibroblasts by arecoline: a possible role in the
pathogenesis of oral submucous fibrosis. J Oral Pathol Med. 2003;32:146-53. |
|
|
|
22.
Haque MF, Harris M, Meghji S, Barrett AW. Immuno- localization of cytokines
and growth factors in oral submucous fibrosis. Cytokine. 1998;10:713-9. |
|
|
|
23.
Meghji S, Scutt A, Harvey W, Canniff JP. An in-vitro comparison of human
fibroblasts from normal and oral submucous fibrosis tissue. Arch Oral Biol.
1987;32:213-5. PMid:3478024 |
|
|
|
24.
Lin HJ, Lin JC. Treatment of oral submucous fibrosis by collagenase: effects
on oral opening and eating function. Oral Dis. 2007;13:407-13. |
|
|
|
25.
Chiu CJ, Chang ML, Chiang CP, Hahn LJ, Hsieh LL, Chen CJ. Interaction of
collagen-related genes and susceptibility to betel quid-induced oral
submucous fibro- sis. Cancer Epidemiol Biomarkers Prev. 2002;11:646-53. PMid:12101112 |
|
|
|
26.
Liu CJ, Lee YJ, Chang KW, Shih YN, Liu HF, Dang CW. Polymorphism of the MICA
gene and risk for oral submucous fibrosis. J Oral Pathol Med. 2004;33:1-6. |
|
|
|
27.
Shin YN, Liu CJ, Chang KW, Lee YJ, Liu HF. Association of CTLA-4 gene
polymorphism with oral submucous fibrosis in Taiwan. J Oral Pathol Med.
2004;33:200-3. |
|
|
|
28.
Tu HF, Liu CJ, Chang CS, et al. The functional (-1171 5A - >6A)
polymorphisms of matrix metalloproteinase 3 gene as a risk factor for oral
submucous fibrosis among male areca users. J Oral Pathol Med. 2006;35:99-103. |
|
|
|
29.
Tzong-Ming Shieh, His-Feng Tu , Ti-Hsuan Ku, Shu-Shin Chang, Kuo-Wei Chang,
Chung-Ji Liu. Association between lysyl oxidase polymorphisms and oral
submucous fibrosis in older male areca chewers. J Oral Pathol Med. 2009;38:109-113. |
|
|
|
30.
Shieh TM, Tu HF, Ku TH, Chang SS, Chang KW, Liu CJ. Association between lysyl
oxidase polymorphisms and oral submucous fibrosis in older male areca
chewers. J Oral Pathol Med. 2009;38:109-13. |
|
|
|
31.
Shieh TM, Lin SC, Liu CJ, Chang SS, Ku TH, Chang KW. Association of
expression aberrances and genetic polymorphisms of lysyl oxidase with
areca-associated oral tumorigenesis. Clin Cancer Res. 2007;13:4378-85. |
|
|
|
32.
Rucker RB, Kosonen T, Clegg MS, Mitchell AE, Rucker BR, Uriu-Hare JY, et al.
Copper, lysyl oxidase, and extracellular matrix protein cross-linking. Am J Clin
Nutr. 1998;67:996-1002. |
|
|
|
33.
Trivedy CR, Warnakualsuriya S, Peters TJ, Senkus R, Hazarey VK, Johnson NW.
Raised tissue copper levels in oral submucous fibrosis. J Oral Pathol Med.
2000;29:241-8. |
|
|
|
34.
Sommer P1, Gleyzal C, Raccurt M, Delbourg M, Serrar M, Joazeiro P,
et al.Transient expression of lysyl oxidase by liver myofibroblasts in murine
schistosomiasis. Lab Invest. 1993;69:460-70. PMid:7901452 |
|
|
|
35.
Shanley CJ, Mehrnaz GK, Sarkar R. Transforming growth factor-b-1 increases
lysyl oxidase activity and mRNA in rat aortic smooth muscle cells. J Vasc
Surg. 1997;25. |
|
|
|
36.
Haque MF, Meghji S, Harris M. Immuno-histochemistry of oral submucous
fibrosis: pre- and post-interferon gamma treatment. Oral Dis. 1997;3:289-91. |
|
|
|
37.
Rucker RB, Romero-Chapman
N, Wong T, Lee J, Steinberg
FM, McGee C,
et al. Modulation of lysyl oxidase by dietary copper in rats. J Nutr.
1996;126:51-60. |
|
|
|
38.
Rucker RB, Kosonen T, Clegg MS. Copper, lysyl oxidase, and extracellular
matrix protein cross-linking. Am J Clin Nutr. 1998;67:996S-1002S. |
|
|
|
39.
Werman MJ, Bhathena SJ, Turnlund JR. Dietary copper intake influences skin
lysyl oxidase in young men. Agricultural Research Service Report
70494.Baltimore: Tektran, 1997; 13. |